About 2 Mg Bortezomib Injection
Experience ravishing results in cancer care with the 2 Mg Bortezomib Injection, a sterling solution for Multiple Myeloma and Mantle Cell Lymphoma. Take advantage of this last chance to maximize your savings with an advance purchase offer. Each single-use vial contains a wondrous lyophilized powder, reconstituted with sterile water for intravenous application. Marketed by Onco Care and meticulously manufactured under license G/28/2282, this prescription-only product delivers uncompromised sterility. With a shelf life of 24 months, store below 25C and protect from light for optimal potency. Ideal for cancer chemotherapy.
Key Features and Versatile Oncology Applications
The 2 Mg Bortezomib Injection boasts a sterile, single-use vial format, designed as an odorless white to off-white lyophilized powder. Utilized primarily in cancer chemotherapy, this formulation is indispensable for treating Multiple Myeloma and Mantle Cell Lymphoma. Suitable for plant-based manufacturing, its advanced composition ensures widespread usage across oncology clinics and hospitals, supporting both primary treatment and combination therapy. It requires reconstitution with sterile water, ensuring precise dosing and application for optimal therapeutic benefit.
Supply Ability, Domestic Market Focus, and Flexible Payment
Backed by a sterling supply chain, Onco Care ensures prompt delivery within the main domestic market across India. Supply ability estimates are available on request, aligning with client demand and urgency. Rates and quotations can be tailored according to order volumes, supporting both large-scale procurement and regular hospital supply. Flexible payment terms are offered to streamline the ordering process, empowering traders, exporters, and local suppliers to obtain this essential oncology solution with confidence.
FAQ's of 2 Mg Bortezomib Injection:
Q: How is 2 Mg Bortezomib Injection administered and what preparation is required?
A: 2 Mg Bortezomib Injection is administered intravenously after reconstitution with sterile water. A healthcare professional carefully prepares and injects the solution as part of prescribed cancer care protocols.
Q: What conditions are treated using the 2 Mg Bortezomib Injection?
A: This injection is primarily indicated for the treatment of Multiple Myeloma and Mantle Cell Lymphoma as part of cancer chemotherapy regimens.
Q: What are the storage requirements for 2 Mg Bortezomib Injection?
A: Store the vial at temperatures below 25C and protect it from light. Always keep it in its original packaging until use to ensure maximum potency and efficacy.
Q: Where can I obtain rate, estimate, or quotation details for this product?
A: You can request rates, estimates, and quotations directly from Onco Care or through authorized distributor channels based on supply needs and order volume.
Q: When should 2 Mg Bortezomib Injection not be used?
A: Do not use the vial after its expiration date or if storage conditions have not been maintained. It should only be used under prescription by qualified healthcare professionals for approved indications.
Q: What are the benefits of advance purchase for this product?
A: Advance purchase secures product availability, ensures timely delivery, and may offer additional savings compared to regular ordering, especially for high-demand periods in oncology settings.